NVO Aug 2024 149.000 call
| Previous close | 3.1500 |
| Open | 3.0000 |
| Bid | 2.9500 |
| Ask | 3.5500 |
| Strike | 149.00 |
| Expiry date | 2024-08-02 |
| Day's range | 3.0000 - 3.1500 |
| Contract range | N/A |
| Volume | |
| Open interest | 167 |
GlobeNewswireNovo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 01 July 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiat
Insider MonkeyThe Top Country With Most Scientists per Capita in the World
We recently compiled a list of the 10 Countries With the Most Scientists per Capita in the World and in this article, we will talk about the top country with the most scientists per capita in the world. Innovation and Growth in the Global Science Industry: AI, Biotechnology, and Market Trends The global science industry […]
ZacksPharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
FDA rejects Merck (MRK) and AbbVie's (ABBV) filings for pipeline candidates. AstraZeneca (AZN) and Novo Nordisk (NVO) announce study failures.
